MedPath

A study to assess the effects of type 2 diabetes mellitus on cognition and depressio

Not Applicable
Conditions
Health Condition 1: null- Type 2 Diabetes Mellitus
Registration Number
CTRI/2017/07/009155
Lead Sponsor
Rizwana Parveen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Cases

1. Men and women aged >=18 years and <=65 years

2. Patients diagnosed with DM2

3. Willingness to give written informed consent

Controls

1. Men and women aged >=18 years and <=65 years

2. Healthy human subjects

3. Willingness to give written informed consent

Exclusion Criteria

Cases

1. Patients with Type 1 DM

2. Patients with a history of severe psychiatric disorders (eg; severe depression, schizophrenia, bipolar disorder)

3. Patients taking any substance of abuse (eg; alcohol, smoking)

4. Patients already on any psychotropic drug

5. Patients with severe complications of diabetes (i.e., amputation, blindness, renal insufficiency and dialysis)

6. Patients having liver disease, renal disease, primary hyperparathyroidism, cancer, HIV and obesity

7. Women who are pregnant or taking oral contraceptive pills

8. Patients taking vitamin D supplement

9. Unwillingness to give written informed consent

Controls

1. Subjects taking vitamin D supplement

2. Unwillingness to give written informed consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath